keyword
https://read.qxmd.com/read/38658803/multimodal-joint-deconvolution-and-integrative-signature-selection-in-proteomics
#21
JOURNAL ARTICLE
Yue Pan, Xusheng Wang, Jiao Sun, Chunyu Liu, Junmin Peng, Qian Li
Deconvolution is an efficient approach for detecting cell-type-specific (cs) transcriptomic signals without cellular segmentation. However, this type of methods may require a reference profile from the same molecular source and tissue type. Here, we present a method to dissect bulk proteome by leveraging tissue-matched transcriptome and proteome without using a proteomics reference panel. Our method also selects the proteins contributing to the cellular heterogeneity shared between bulk transcriptome and proteome...
April 24, 2024: Communications Biology
https://read.qxmd.com/read/38658755/mechanism-of-single-stranded-dna-annealing-by-rad52-rpa-complex
#22
JOURNAL ARTICLE
Chih-Chao Liang, Luke A Greenhough, Laura Masino, Sarah Maslen, Ilirjana Bajrami, Marcel Tuppi, Mark Skehel, Ian A Taylor, Stephen C West
RAD52 is important for the repair of DNA double-stranded breaks1,2 , mitotic DNA synthesis3-5 and alternative telomere length maintenance6,7 . Central to these functions, RAD52 promotes the annealing of complementary single-stranded DNA (ssDNA)8,9 and provides an alternative to BRCA2/RAD51-dependent homologous recombination repair10 . Inactivation of RAD52 in homologous-recombination-deficient BRCA1- or BRCA2-defective cells is synthetically lethal11,12 , and aberrant expression of RAD52 is associated with poor cancer prognosis13,14 ...
April 24, 2024: Nature
https://read.qxmd.com/read/38658600/kataegis-in-clinical-and-molecular-subgroups-of-primary-breast-cancer
#23
JOURNAL ARTICLE
Srinivas Veerla, Johan Staaf
Kataegis is a hypermutation phenomenon characterized by localized clusters of single base pair substitution (SBS) reported in multiple cancer types. Despite a high frequency in breast cancer, large-scale analyses of kataegis patterns and associations with clinicopathological and molecular variables in established breast cancer subgroups are lacking. Therefore, WGS profiled primary breast cancers (n = 791) with associated clinical and molecular data layers, like RNA-sequencing data, were analyzed for kataegis frequency, recurrence, and associations with genomic contexts and functional elements, transcriptional patterns, driver alterations, homologous recombination deficiency (HRD), and prognosis in tumor subgroups defined by ER, PR, and HER2/ERBB2 status...
April 24, 2024: NPJ Breast Cancer
https://read.qxmd.com/read/38658568/a-high-cholesterol-diet-promotes-the-intravasation-of-breast-tumor-cells-through-an-ldl-ldlr-axis
#24
JOURNAL ARTICLE
Ana Magalhães, Vanessa Cesário, Diogo Coutinho, Inês Matias, Germana Domingues, Catarina Pinheiro, Teresa Serafim, Sérgio Dias
Most metastases in breast cancer occur via the dissemination of tumor cells through the bloodstream. How tumor cells enter the blood (intravasation) is, however, a poorly understood mechanism at the cellular and molecular levels. Particularly uncharacterized is how intravasation is affected by systemic nutrients. High levels of systemic LDL-cholesterol have been shown to contribute to breast cancer progression and metastasis in various models, but the cellular and molecular mechanisms involved are still undisclosed...
April 24, 2024: Scientific Reports
https://read.qxmd.com/read/38658495/correction-the-association-of-pten-gene-mutations-with-the-breast-cancer-risk-a-systematic-review-and-meta-analysis
#25
Kheirollah Yari, Ali Hakimi, Masoud Mohammadi, Mojtaba Ammari-Allahyari, Nader Salari, Hooman Ghasemi
No abstract text is available yet for this article.
April 24, 2024: Biochemical Genetics
https://read.qxmd.com/read/38658494/identification-of-key-lncrnas-associated-with-immune-infiltration-and-prognosis-in-gastric-cancer
#26
JOURNAL ARTICLE
Wen Jin, Jianchao Jia, Yangming Si, Jianli Liu, Hanshuang Li, Hao Zhu, Zhouying Wu, Yongchun Zuo, Lan Yu
Long non-coding RNAs (lncRNAs), as promising novel biomarkers for cancer treatment and prognosis, can function as tumor suppressors and oncogenes in the occurrence and development of many types of cancer, including gastric cancer (GC). However, little is known about the complex regulatory system of lncRNAs in GC. In this study, we systematically analyzed lncRNA and miRNA transcriptomic profiles of GC based on bioinformatics methods and experimental validation. An lncRNA-miRNA interaction network related to GC was constructed, and the nine crucial lncRNAs were identified...
April 24, 2024: Biochemical Genetics
https://read.qxmd.com/read/38658487/high-grade-endometrial-cancer-molecular-subtypes-current-challenges-and-treatment-options
#27
REVIEW
Yusuke Matoba, Kyle M Devins, Lara Milane, William B Manning, Varvara Mazina, Oladapo O Yeku, Bo R Rueda
Although many recent advancements have been made in women's health, perhaps one of the most neglected areas of research is the diagnosis and treatment of high-grade endometrial cancer (EnCa). The molecular classification of EnCa in concert with histology was a major step forward. The integration of profiling for mismatch repair deficiency and Human Epidermal Growth Factor 2 (HER2) overexpression, can further inform treatment options, especially for drug resistant recurrent disease. Recent early phase trials suggest that regardless of subtype, combination therapy with agents that have distinct mechanisms of action is a fruitful approach to the treatment of high-grade EnCa...
April 24, 2024: Reproductive Sciences
https://read.qxmd.com/read/38658129/stable-feature-selection-utilizing-graph-convolutional-neural-network-and-layer-wise-relevance-propagation-for-biomarker-discovery-in-breast-cancer
#28
JOURNAL ARTICLE
Hryhorii Chereda, Andreas Leha, Tim Beißbarth
High-throughput technologies are becoming increasingly important in discovering prognostic biomarkers and in identifying novel drug targets. With Mammaprint, Oncotype DX, and many other prognostic molecular signatures breast cancer is one of the paradigmatic examples of the utility of high-throughput data to deliver prognostic biomarkers, that can be represented in a form of a rather short gene list. Such gene lists can be obtained as a set of features (genes) that are important for the decisions of a Machine Learning (ML) method applied to high-dimensional gene expression data...
May 2024: Artificial Intelligence in Medicine
https://read.qxmd.com/read/38657992/the-evolvement-of-breast-cancer-therapies-what-we-have-done-and-where-all-these-head-off
#29
REVIEW
Ika Nurlaila, Sabar Pambudi
Although, from a therapeutic standpoint, breast cancer (BC) is considerably well-characterized, it still leaves puzzling spots. The Her-2+/PR+/ER+ BC can benefit from the mainstays of anticancer therapy and immunotherapy and overall have a better prognosis. Triple-negative BC, due to the concomitant absence of Her-2/PR/ER receptors, is more challenging and necessitates different strategies. It has been learned that the mainstay anti-BC therapies were initially designed to demolish as many cancer cells as they possibly could...
April 2024: Saudi Medical Journal
https://read.qxmd.com/read/38657712/bisphenol-s-enhances-the-cell-proliferation-ability-of-prostate-cancer-cells-by-regulating-the-expression-of-sds
#30
JOURNAL ARTICLE
Guanqun Ju, Xiangyang Zhan, Xinglin Chen, Tongtong Zhang, Xinyu Zhai, Chuanmin Chu, Mingyue Tan, Dongliang Xu
Recent times have witnessed an increase in both incidence and mortality rates of prostate cancer. While some individuals with localized or metastatic cancer may progress slowly with a lower mortality risk, those with intermediate or high-risk cancer often face a higher likelihood of death, despite treatment. Bisphenol A (BPA) has been linked to various cancers, including prostate and breast cancer, yet the relationship between bisphenol S (BPS) and human health remains underexplored. In our study, we employed ssGSEA analysis to evaluate the BPS-associated score in a prostate cancer cohort...
April 22, 2024: Toxicology in Vitro: An International Journal Published in Association with BIBRA
https://read.qxmd.com/read/38657699/estrogen-receptor-beta-expression-and-role-in-cancers
#31
JOURNAL ARTICLE
Fátima L Monteiro, Lina Stepanauskaite, Amena Archer, Cecilia Williams
Estrogen drives the growth of some cancers, such as breast cancer, via estrogen receptor alpha (ERβ). Estrogen also activates ERβ, but whether ERβ is expressed and has a role in different cancers is debated. The use of nonspecific antibodies has contributed to the confusion, and this review delves into ERβ's controversial role in cancer and focuses on tumor expression that can be supported by non-antibody-dependent assays. We discuss its expression at the transcript level and focus on its potential role in lymphoma, granulosa cell tumor, testicular, and adrenal cancers, emphasizing recent findings and the complexities that necessitate further research...
April 22, 2024: Journal of Steroid Biochemistry and Molecular Biology
https://read.qxmd.com/read/38657288/optimising-a-self-assembling-peptide-hydrogel-as-a-matrigel-alternative-for-3-dimensional-mammary-epithelial-cell-culture
#32
JOURNAL ARTICLE
Eliana Lingard, Siyuan Dong, Anna Hoyle, Ellen Appleton, Alis Hales, Eldhose Skaria, Craig Lawless, Isobel Taylor-Hearn, Simon Saadati, Qixun Chu, Aline F Miller, Marco Domingos, Alberto Saiani, Joe Swift, Andrew P Gilmore
Three-dimensional (3D) organoid models have been instrumental in understanding molecular mechanisms responsible for many cellular processes and diseases. However, established organic biomaterial scaffolds used for 3D hydrogel cultures, such as Matrigel, are biochemically complex and display significant batch variability, limiting reproducibility in experiments. Recently, there has been significant progress in the development of synthetic hydrogels for in vitro cell culture that are reproducible, mechanically tuneable, and biocompatible...
March 28, 2024: Biomater Adv
https://read.qxmd.com/read/38656005/predictors-of-recurrence-in-breast-cancer-patients-with-pathological-partial-response
#33
JOURNAL ARTICLE
Fadime Didem Can Trabulus, Mehmet Ali Nazli, Esra Arslan, Ozlem Mermut, Fatih Dal, Bulent Akce, Riza Umar Gursu, Esra Canan Kelten Talu, Jacqueline Nur Adira Couteau
OBJECTIVE: Patients with residual disease after neoadjuvant chemotherapy have a relative risk of developing recurrence. This study investigates the risk factors for recurrence in locally advanced breast cancer patients with residual disease and evaluates survival analysis. METHODS: This is a retrospective, single-center study. Breast cancer patients who failed to achieve a pathological complete response after neoadjuvant chemotherapy were included. Demographic, clinicopathological, and treatment characteristics were evaluated to identify predictive factors of recurrence and survival analysis...
2024: Revista da Associação Médica Brasileira
https://read.qxmd.com/read/38655907/artificial-intelligence-in-digital-histopathology-for-predicting-patient-prognosis-and-treatment-efficacy-in-breast-cancer
#34
REVIEW
William M Gallagher, Christine McCaffrey, Chowdhury Jahangir, Clodagh Murphy, Caoimbhe Burke, Arman Rahman
INTRODUCTION: Histological images contain phenotypic information predictive of patient outcomes. Due to the heavy workload of pathologists, the time-consuming nature of quantitatively assessing histological features, and human eye limitations to recognize spatial patterns, manually extracting prognostic information in routine pathological workflows remains challenging. Digital pathology has facilitated the mining and quantification of these features utilizing whole-slide image (WSI) scanners and artificial intelligence (AI) algorithms...
April 24, 2024: Expert Review of Molecular Diagnostics
https://read.qxmd.com/read/38655709/retraction-mir-655-suppresses-epithelial-to-mesenchymal-transition-by-targeting-prrx1-in-triple-negative-breast-cancer
#35
(no author information available yet)
Zhi-Dong Lv, Bin Kong, Xiang-Ping Liu, Li-Ying Jin, Qian Dong, Fu-Nian Li, Hai-Bo Wang, miR-655 suppresses epithelial-to-mesenchymal transition by targeting Prrx1 in triple-negative breast cancer. Journal of Cellular and Molecular Medicine, 20: 864-873. https://doi.org/10.1111/jcmm.12770 The above article, published online on 28 January 2016 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the authors, the journal Editor-in-Chief, Stefan Constantinescu, The Foundation for Cellular and Molecular Medicine, and John Wiley and Sons Ltd...
April 2024: Journal of Cellular and Molecular Medicine
https://read.qxmd.com/read/38655619/dpp3-promotes-breast-cancer-tumorigenesis-by-stabilizing-fasn-and-promoting-lipid-synthesis
#36
JOURNAL ARTICLE
Xiaoyu Fu, Xu Li, Weixing Wang, Juanjuan Li
DPP3, a dipeptidyl peptidase, participates in a variety of pathophysiological processes. DPP3 is upregulated in cancer and might serve as a key factor in the tumorigenesis and progression of various malignancies. However, its specific role and molecular mechanism are still unknown. In this study, the expression of DPP3 in breast cancer tissues is analyzed using TCGA database. Kaplan-Meier survival analysis is performed to estimate the effect of DPP3 on the survival outcomes. To explore the biological function and mechanisms of DPP3 in breast cancer, biochemical and cell biology assays are conducted in vitro ...
April 24, 2024: Acta Biochimica et Biophysica Sinica
https://read.qxmd.com/read/38655099/molecular-interaction-and-md-simulations-investigation-of-sizofiran-as-a-promising-anti-cancer-agent-targeting-eif4e-in-colorectal-cancer
#37
JOURNAL ARTICLE
Gopinath Samykannu, Nandhini Mariyappan, Jeyakumar Natarajan
UNLABELLED: CRC has a major global health impact due to high mortality rates. CRC shows high expression of eukaryotic translation initiation factor (eIF4E) protein, the rapid development of lung, bladder, colon, prostate, breast, head, and neck cancer is attributed to the dysregulation of eIF4E making an important target for treatment. Targeting eIF4E-mediated translation is a promising anti-cancer strategy. Many organic compounds that inhibit eIF4E are being studied clinically. The compound Sizofiran has emerged as a promising eIF4E inhibitor candidate, but its exact mechanism of action is unclear...
2024: In Silico Pharmacology
https://read.qxmd.com/read/38654356/chemotherapy-elicited-extracellular-vesicle-cxcl1-from-dying-cells-promotes-triple-negative-breast-cancer-metastasis-by-activating-tam-pd-l1-signaling
#38
JOURNAL ARTICLE
Shengqi Wang, Jing Li, Shicui Hong, Neng Wang, Shang Xu, Bowen Yang, Yifeng Zheng, Juping Zhang, Bo Pan, Yudie Hu, Zhiyu Wang
BACKGROUND: Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer, and chemotherapy still serves as the cornerstone treatment functioning by inducing cytotoxic cell death. Notably, emerging evidence suggests that dying cell-released signals may induce cancer progression and metastasis by modulating the surrounding microenvironment. However, the underlying molecular mechanisms and targeting strategies are yet to be explored. METHODS: Apoptotic TNBC cells induced by paclitaxel or adriamycin treatment were sorted and their released extracellular vesicles (EV-dead) were isolated from the cell supernatants...
April 23, 2024: Journal of Experimental & Clinical Cancer Research: CR
https://read.qxmd.com/read/38654332/amd1-promotes-breast-cancer-aggressiveness-via-a-spermidine-eif5a-hypusination-tcf4-axis
#39
JOURNAL ARTICLE
Ruocen Liao, Xingyu Chen, Qianhua Cao, Longchang Bai, Chenglong Ma, Zhijun Dai, Chenfang Dong
BACKGROUND: Basal-like breast cancer (BLBC) is the most aggressive subtype of breast cancer due to its aggressive characteristics and lack of effective therapeutics. However, the mechanism underlying its aggressiveness remains largely unclear. S-adenosylmethionine decarboxylase proenzyme (AMD1) overexpression occurs specifically in BLBC. Here, we explored the potential molecular mechanisms and functions of AMD1 promoting the aggressiveness of BLBC. METHODS: The potential effects of AMD1 on breast cancer cells were tested by western blotting, colony formation, cell proliferation assay, migration and invasion assay...
April 23, 2024: Breast Cancer Research: BCR
https://read.qxmd.com/read/38654231/systematic-optimization-and-evaluation-of-culture-conditions-for-the-construction-of-circulating-tumor-cell-clusters-using-breast-cancer-cell-lines
#40
JOURNAL ARTICLE
Jueyao Zou, Qiong Chen, Yong He, Yanhong Pan, Han Zhao, Junfeng Shi, Zhonghong Wei, Suyun Yu, Yang Zhao, Xin Han, Yin Lu, Wenxing Chen
BACKGROUND: Circulating tumor cell (CTC) clusters play a critical role in carcinoma metastasis. However, the rarity of CTC clusters and the limitations of capture techniques have retarded the research progress. In vitro CTC clusters model can help to further understand the biological properties of CTC clusters and their clinical significance. Therefore, it is necessary to establish reliable in vitro methodological models to form CTC clusters whose biological characteristics are very similar to clinical CTC clusters...
April 23, 2024: BMC Cancer
keyword
keyword
105821
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.